indazoles has been researched along with Lymphoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Albakova, Z; Mangasarova, Y; Sapozhnikov, A | 1 |
| Alarcon, SV; Brega, N; Crandon, S; Figg, WD; Giaccone, G; Gutierrez, M; Houk, BE; Jain, L; Kelly, RJ; Kim, YS; Kummar, S; Mannargudi, B; Rajan, A; Shnaidman, M; Trepel, JB; Zein, WM | 1 |
| Allain, CJ; Chesworth, R; Copeland, RA; Jin, L; Keilhack, H; Klaus, CR; Knutson, SK; Kuntz, KW; Majer, CR; Moyer, MP; Olhava, EJ; Pollock, RM; Raimondi, A; Richon, VM; Sacks, JD; Scott, MP; Smith, JJ; Sneeringer, CJ; Song, J; Warholic, NM; Wigle, TJ | 1 |
| Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K | 1 |
| Cohen, JD; Lagoni, R; Longo, WL; Neville, AJ; O'Keefe, S; Riggs, C; Robins, HI; Schmitt, CL; Steeves, RA | 1 |
| Covelli, A; De Fabritiis, P; De Felice, L; Mandelli, F; Pulsoni, A; Sandrelli, A; Simone, F; Zupi, G | 1 |
| Clive, D | 1 |
1 review(s) available for indazoles and Lymphoma
| Article | Year |
|---|---|
Heat Shock Proteins in Lymphoma Immunotherapy.
Topics: Animals; Benzamides; Benzodioxoles; Glycine; Heat-Shock Proteins; Humans; Immunotherapy; Immunotherapy, Adoptive; Indazoles; Isoxazoles; Lymphoma; Molecular Targeted Therapy; Purines; Resorcinols | 2021 |
3 trial(s) available for indazoles and Lymphoma
| Article | Year |
|---|---|
A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas.
Topics: Adult; Aged; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glycine; HSP90 Heat-Shock Proteins; Humans; Indazoles; Lymphoma; Male; Middle Aged; Neoplasms | 2011 |
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting | 1993 |
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Cell Line; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; In Vitro Techniques; Indazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Mice; Mice, Inbred AKR; Middle Aged; Pilot Projects; Pyrazoles; Whole-Body Irradiation | 1990 |
3 other study(ies) available for indazoles and Lymphoma
| Article | Year |
|---|---|
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.
Topics: Antineoplastic Agents; Cell Cycle; Cell Death; Cell Proliferation; Dose-Response Relationship, Drug; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histones; Humans; Indazoles; Lymphoma; Lysine; Methylation; Molecular Structure; Point Mutation; Polycomb Repressive Complex 2; Pyridones; Structure-Activity Relationship | 2012 |
In vitro pharmacological purging of human bone marrow is enhanced by the use of lonidamine.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow; Cell Line; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indazoles; Lymphoma; Neoplastic Stem Cells; Pyrazoles | 1989 |
Recent developments with the L5178Y TK heterozygote mutagen assay system.
Topics: Alkylating Agents; Animals; Cell Line; Cell Membrane Permeability; Cells, Cultured; Dose-Response Relationship, Drug; Ethane; Ethylenediamines; Genetic Techniques; Heterozygote; Hydrocarbons, Brominated; Indazoles; Lucanthone; Lymphoma; Mesylates; Methanol; Mice; Mutagens; Mutation; Radiation Effects; Thioxanthenes; Thymidine Kinase | 1973 |